Dewpoint Therapeutics, biotech startup in a once-buzzy field, cuts 70% of staff

Dewpoint Therapeutics, biotech startup in a once-buzzy field, cuts 70% of staff

The company is focused on medicines using bimolecular condensates, which became a hot area of investment around 2020 but have since cooled.

Dewpoint Therapeutics cuts workforce, refocuses pipeline - European Biotechnology Magazine

Dewpoint Therapeutics Inc. has announced a significant corporate restructuring. Approximately 70% of its 130 employees will be laid off, and operations will be consolidated at the company’s Boston headquarters. The company will close its two German locations in Frankfurt and Dresden and streamline its pipeline. The post Dewpoint Therapeutics cuts workforce, refocuses pipeline appeared first on European Biotechnology Magazine.

Dewpoint downsizes while in 'final stages' of getting more funds for first trial

A biotech that hoped to spearhead a formerly hot area of drug development is letting go of staff as its runway dries up. The Boston-based startup, Dewpoint Therapeutics, has “undertaken a strategic consolidation” that includes ...